Abbott Laboratories Earnings Preview: Can This Streak Continue?

Abbott Laboratories (NYSE:ABT) will report earnings before markets open on Wednesday, April 17th. Abbott Laboratories discovers, develops, manufactures, and sells a broad and diversified line of health care products and services. The Company’s products include pharmaceuticals, nutritional, diagnostics, and vascular products. Abbott markets its products worldwide through affiliates and distributors.

Here is your Cheat Sheet to Abbott Laboratories Earnings:

Earnings Expectations: Analysts expect earnings of $0.41 per share on revenues of $5.42 billion. Currently, the company’s P/E ratio stands at 9.97.

Analyst Trends:

Analysts have a more negative outlook for the company’s next-quarter performance. Over the past three months, the average estimate for next quarter’s earnings has fallen from a profit of $0.49 to a profit $0.45. For the current year, the average estimate is a profit of $2.01, which is better than the estimate ninety days ago.

Earnings Trends:

Here’s how Abbott Laboratories has been performing on an annual basis:

Fiscal Year 2008 2009 2010 2011 2012
Revenue ($) in millions 29,530 30,760 35,170 38,850 39,870
Diluted EPS ($) 3.12 3.69 2.96 3.01 3.72

Next, our CHEAT SHEET investing framework asks us to drill down to the recent quarterly data:

Quarter Dec. 31, 2011 Mar. 31, 2012 Jun. 30, 2012 Sep. 30, 2012 Dec. 31, 2012
Revenue ($) in millions 10,380 9,457 9,807 9,773 10,840
Diluted EPS ($) 1.04 0.78 1.08 1.21 0.65

Past Performance:
Abbott Laboratories has beat analyst estimates 4 times in the past four quarters. Shareholders could expect a boost if the company beats estimates.

“E = Earnings Are Increasing Quarter-Over-Quarter” is a core component of our successful CHEAT SHEET investing framework. Don’t waste another minute – click here to discover our CHEAT SHEET stock picks now!

(Company fundamentals provided by Xignite Financials. Email any earnings discrepancies to earnings [at]